Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,041.28
(
0.26%
)
US TECH 100
25,608.00
(
0.44%
)
Dow Jones
48,578.72
(
0.24%
)
Brent Oil
94.86
(
-0.16%
)
Bitcoin
74,748.33
(
-0.58%
)
News Focus
News Focus
Post# of 447355
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Whalatane

Send PM Follow Ignore
Followers 142
Posts 23860
Boards Moderated 0
Alias Born 06/13/2011

Whalatane

Re: Laurent Maldague post# 417717

Monday, 11/06/2023 12:05:46 AM

Monday, November 06, 2023 12:05:46 AM

Post# of 447355
Path of least resistance to FDA approval is a Clarity AD / Trailblazer-Alz-2 type P3 trial ( thx for noting those previously ) .
Since Vascepa has a well documented safety record as an approved drug ...trial should enroll very quickly ....PET scans make this a lot more patient friendly .
Kiwi
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News